IRVINE, Calif., April 23, 2009 (GLOBE NEWSWIRE) -- Microsemi Corporation (Nasdaq:MSCC) today reported unaudited results for its second quarter of fiscal year 2009.
* Net Sales for Second Quarter Totaled $105.7 Million * Operating Cash Flow for Second Quarter Increased 9.7% Over Prior Quarter to $24.0 Million * All Auction Rate Securities Monetized at Full Par Value of $46.6 Million * Cash Balance Reached a Record High of $185.8 Million
Net sales for Microsemi's second quarter ended March 29, 2009 were $105.7 million, down 16.6 percent from net sales of $126.7 million in the second quarter of 2008, and down 19.1 percent from net sales of $130.6 million in the first quarter of 2009.
Non-GAAP gross margin in the second quarter of 2009 was 47.1 percent, compared to 51.5 percent in the second quarter of 2008 and 51.8 percent in the first quarter of 2009. Non-GAAP operating margin was 17.2 percent in the second quarter of 2009 compared to 26.1 percent in the second quarter of 2008 and 26.9 percent in the first quarter of 2009. For the second quarter of 2009, non-GAAP net income was $14.8 million, compared to $25.3 million in non-GAAP net income in the second quarter of 2008 and $28.7 million in non-GAAP net income in the first quarter of 2009. For the second quarter of 2009, the non-GAAP effective tax rate was 19.5 percent. Non-GAAP diluted earnings per share in the second quarter of 2009 were $0.19 compared to $0.32 in the second quarter of 2008 and $0.36 in the first quarter of 2009.
GAAP gross margin for the second quarter of 2009 was 31.0 percent compared to 43.6 percent in the second quarter of 2008 and 46.2 percent in the first quarter of 2009. GAAP operating margin was a loss of 15.9 percent in the second quarter of 2009 compared to a profit of 9.8 percent in the second quarter of 2008 and 10.7 percent in the first quarter of 2009. GAAP results in the second quarter of 2009 included $6.3 million for transitional idle capacity, a reduction of $0.7 million from the previous quarter, and $16.0 million in restructuring and related charges, including $10.2 million in inventory write-downs, $4.5 million in severance benefits, $0.6 million in impairment of restructuring related fixed assets and $0.7 million in other related charges. Also included in the second quarter of 2009 were non-cash charges of $7.0 million related to stock based compensation and $3.6 million in amortization of acquisition-related intangibles. The inventory write-down component relates to product lines that do not meet gross margin targets, products that are being migrated to newer generations, and products that service the large capital spending end markets for which demand has declined. For the second quarter of 2009, GAAP net loss was $16.6 million compared to GAAP net income of $9.8 million in the second quarter of 2008 and $13.2 million in GAAP net income in the first quarter of 2009. For the second quarter of 2009, the GAAP effective tax rate was negative 0.5 percent. GAAP diluted loss per share in the second quarter of 2009 was $0.21, compared to diluted earnings per share of $0.12 in the second quarter of 2008, and diluted earnings per share of $0.16 in the first quarter of 2009.
James J. Peterson, President and Chief Executive Officer, stated, "Our second quarter was challenging. This was especially evident in our commercially targeted markets which have been impacted by the macroeconomic environment. However, our cost cutting and spending controls have positioned us to more effectively influence profitability, where we will see improvement in our gross, operating and net margin metrics. These improvements were again reflected in our operating cash flow with another strong increase of $24.0 million, giving us increased leverage for continued strategic initiatives."
Business Outlook
Microsemi expects that for the third quarter of fiscal year 2009, our net sales will be between a range of minus 3 percent and plus 2 percent, sequentially. On a non-GAAP basis, we expect earnings for the third quarter of fiscal year 2009 to be $0.19 to $0.21 per diluted share.
Microsemi regularly announces a quarterly outlook in the form of issuing a news release and does not undertake to update any of this information between such public announcements. Please refer to the "SAFE HARBOR" STATEMENT below for risks that may affect future actual results.
Non-GAAP results are explained and reconciled to GAAP results in the attached tables. Non-GAAP financial measures exclude items such as transitional idle capacity and inventory abandonments, amortization of acquisition-related intangible assets, effects of manufacturing profit in acquired inventory, stock based compensation, in-process research and development, restructuring, reserve valuations and other special charges or credits.
About Microsemi Corporation
Microsemi, with corporate headquarters in Irvine, California, is a leading designer, manufacturer and marketer of high performance analog and mixed signal integrated circuits and high reliability semiconductors. The Company's semiconductors manage and control or regulate power, protect against transient voltage spikes and transmit, receive, and amplify signals.
Microsemi's products include individual components as well as integrated circuit solutions that enhance customer designs by improving performance and reliability, optimizing battery performance, reducing size or protecting circuits. The principal markets the company serves include defense, commercial air, satellite, medical, notebook computers, LCD TVs, mobile, and connectivity applications. More information may be obtained by contacting the company directly or by visiting its website at http://www.microsemi.com.
The Microsemi Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=1233
Information for Second Quarter 2009 Earnings Conference Call and Webcast
Date: Thursday, April 23, 2009 Time: 4:45 pm Eastern Daylight Time (1:45 pm Pacific Daylight Time)
To access the webcast, please log on to: www.microsemi.com and go to Investors and then to Events and Presentations. To listen to the live webcast, please go to this website approximately fifteen minutes prior to the start of the call to register, download, and install any necessary audio software. For those unable to participate during the live webcast, a replay will be available shortly after the call on the website for 90 days.
To participate in the conference call by telephone, please call: (877) 264-1110 or (706) 634-1357 at approximately 4:35 pm EDT (1:35 pm PDT). Please provide the following ID Number: 95749485.
A telephonic replay will be available from 6:00 pm EDT (3:00 pm PDT) on Thursday, April 23, 2009 through 11:59 pm EDT (8:59 pm PDT) on Thursday, April 30th. To access the replay, please call (800) 642-1687 or (706) 645-9291. Please enter the following ID Number: 95749485.
PLEASE READ THE FOLLOWING FACTORS THAT CAN MATERIALLY AFFECT MICROSEMI'S FUTURE RESULTS.
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Any statements set forth in the news release that are not entirely historical and factual in nature are forward-looking statements, including without limitation statements concerning our expectations regarding our business outlook, our performance and competitive position during the coming quarter and year, expectation regarding the change in our end markets, our belief that we will continue to make operational and efficiency improvements in order to better service our customers and to give us increased leverage for continued strategic initiatives, and any other statements of belief or about our plans or expectations. These forward-looking statements are based on our current expectations and are inherently subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. The potential risks and uncertainties include, but are not limited to, such factors as the uncertainty of litigation, the costs and expenses of litigation, the potential material adverse effect litigation could have on Microsemi's business and results of operations, if an adverse determination in litigation is made, and the time and attention required of management to attend to litigation, changes in generally accepted accounting principles, the difficulties regarding the making of estimates and projections, the hiring and retention of qualified personnel in a competitive labor market, acquiring, managing and integrating new operations, businesses or assets, uncertainty as to the future profitability of acquired businesses, delays in the realization of any accretion from acquisition transactions, any circumstances that adversely impact the end markets of acquired businesses, difficulties in closing or disposing of operations or assets, difficulties in transferring work from one plant to another, rapidly changing technology and product obsolescence, difficulties predicting the timing and amount of plant closure costs, the potential inability to realize cost savings or productivity gains and to improve capacity utilization, potential cost increases, weakness or competitive pricing environment of the marketplace, uncertain demand for and acceptance of the company's products, adverse circumstances in any of our end markets, results of in-process or planned development or marketing and promotional campaigns, changes in demand for products, difficulties foreseeing future demand, effects of limited visibility of future sales, potential non-realization of expected orders or non-realization of backlog, product returns, product liability, and other potential unexpected business and economic conditions or adverse changes in current or expected industry conditions, business disruptions, epidemics, health advisories, disasters, national emergencies, wars or potential future effects of the tragic events of September 11, 2001, political instability, currency fluctuations, principal and liquidity risks associated with our investments including auction rate securities, variations in customer order preferences, fluctuations in market prices of the company's common stock and potential unavailability of additional capital on favorable terms, difficulties in implementing company strategies, dealing with environmental or other regulatory matters or litigation, or any matters involving litigation, contingent liabilities or other claims, difficulties and costs imposed by law, including under the Sarbanes-Oxley Act of 2002, difficulties in determining the scope of, and procuring and maintaining, adequate insurance coverage, difficulties and costs of protecting patents and other proprietary rights, work stoppages, labor issues, inventory obsolescence and difficulties regarding customer qualification of products, manufacturing facilities and processes, and other difficulties managing consolidation or growth, including in the maintenance of internal controls, the implementation of information systems, and the training of personnel. In addition to these factors and any other factors mentioned elsewhere in this news release, the reader should refer as well to the factors, uncertainties or risks identified in the company's most recent Form 10-K and all subsequent Form 10-Q reports filed by Microsemi with the SEC. Additional risk factors may be identified from time to time in Microsemi's future filings. The forward-looking statements included in this release speak only as of the date hereof, and Microsemi does not undertake any obligation to update these forward-looking statements to reflect subsequent events or circumstances. Amounts reported in this release are preliminary and subject to finalization prior to the filing of our Form 10-Q, which is expected to occur no later than May 8, 2009.
To supplement the consolidated financial results prepared in accordance with Generally Accepted Accounting Principles ("GAAP"), this press release and its attachments include non-GAAP financial measures that exclude transitional idle capacity, inventory reserves due to restructuring activities, impairment of restructuring related fixed assets, effects of manufacturing profit in acquired inventory, amortization of acquisition-related intangible assets, stock based compensation, in-process research and development, restructuring, reserve valuations and other special charges or credits. Management excludes these items because it believes that the non-GAAP measures enhance an investor's overall understanding of the Company's financial performance and future prospects by being more reflective of the Company's core operational activities and to be more comparable with the results of the Company over various periods. Management uses non-GAAP financial measures internally for strategic decision making, forecasting future results and evaluating current performance. Guidance is provided only on a non-GAAP basis due to the inherent difficulty of forecasting the timing or amount of certain items that have been excluded from the forward-looking non-GAAP measures, and a reconciliation to the comparable GAAP guidance has not been provided because certain factors that are materially significant to the Company's ability to estimate the excluded items are not accessible or estimable on a forward-looking basis. By disclosing non-GAAP financial measures, management intends to provide investors with a more meaningful, consistent comparison of the Company's core operating results and trends for the periods presented. Non-GAAP financial measures are not prepared in accordance with GAAP; therefore, the information is not necessarily comparable to other companies' financial information and should be considered as a supplement to, not a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP.
Investor Inquiries: Robert C. Adams, Microsemi Corporation, Irvine, CA (949) 221-7100.
MICROSEMI CORPORATION
Consolidated Income Statements
(Unaudited, in thousands, except per share amounts)
Quarter ended Six months ended
-------------------- --------------------
March 29, March 30, March 29, March 30,
2009 2008 2009 2008
--------- --------- --------- ---------
NET SALES $ 105,693 $ 126,665 $ 236,287 $ 250,139
Cost of sales 72,981 71,466 143,142 142,406
--------- --------- --------- ---------
GROSS MARGIN 32,712 55,199 93,145 107,733
Operating expenses:
Selling, general and
administrative 31,218 26,494 61,823 53,255
Research and development 10,209 11,295 20,976 22,449
Amortization of
intangible assets 3,562 2,816 6,806 5,915
Restructuring charges 4,528 2,171 6,433 2,213
In-process research and
development -- -- -- 440
--------- --------- --------- ---------
Total operating
expenses 49,517 42,776 96,038 84,272
--------- --------- --------- ---------
OPERATING INCOME (LOSS) (16,805) 12,423 (2,893) 23,461
Interest and other
income, net 270 703 943 1,821
--------- --------- --------- ---------
INCOME (LOSS) BEFORE
INCOME TAXES (16,535) 13,126 (1,950) 25,282
Provision for income
taxes 77 3,311 1,454 6,854
--------- --------- --------- ---------
NET INCOME (LOSS) $ (16,612) $ 9,815 $ (3,404) $ 18,428
========= ========= ========= =========
Earnings (loss) per share
Basic $ (0.21) $ 0.13 $ (0.04) $ 0.24
========= ========= ========= =========
Diluted $ (0.21) $ 0.12 $ (0.04) $ 0.23
========= ========= ========= =========
Common and common
equivalent shares
outstanding:
Basic 79,451 77,689 79,332 77,167
Diluted 79,451 79,518 79,332 79,245
MICROSEMI CORPORATION
Schedule Reconciling Non-GAAP Net Income to GAAP Net Income (Loss)
(Unaudited, in thousands, except per share amounts)
Quarter ended Six months ended
-------------------- --------------------
March 29, March 30, March 29, March 30,
2009 2008 2009 2008
--------- --------- --------- ---------
GAAP NET INCOME (LOSS) $ (16,612) $ 9,815 $ (3,404) $ 18,428
========= ========= ========= =========
The non-GAAP amounts have
been adjusted to exclude
the following items:
Excluded from cost of
sales
Transitional idle
capacity (a) $ 6,271 $ 9,976 $ 13,201 $ 20,741
Inventory reserves due
to restructuring
activities (a) 10,204 -- 10,204 --
Impairment of
restructuring related
fixed assets (a) 590 -- 590 --
Manufacturing profit in
acquired inventory (b) -- -- 243 --
Excluded from operating
expenses
Amortization of
intangible assets (c) 3,562 2,816 6,806 5,915
Stock based
compensation (d) 6,976 5,184 14,891 11,325
In-process research and
development (e) -- -- -- 440
Exceptional legal
expenses (f) 2,111 -- 2,557 --
Restructuring and other
special charges (a) 5,219 2,677 7,640 3,506
--------- --------- --------- ---------
34,933 20,653 56,132 41,927
Income tax effect on
non-GAAP adjustments (g) 3,511 5,134 9,194 10,617
--------- --------- --------- ---------
Net effect of adjustments
to GAAP net income $ 31,422 $ 15,519 $ 46,938 $ 31,310
========= ========= ========= =========
NON-GAAP NET INCOME $ 14,810 $ 25,334 $ 43,534 $ 49,738
========= ========= ========= =========
(a) - (g) Please refer to corresponding footnotes below.
MICROSEMI CORPORATION
Schedule Reconciling Reported Non-GAAP Financial Ratios to Comparable
GAAP Financial Ratios
(Unaudited)
Quarter ended
----------------------------------------------
March 29, December 28, March 30,
2009 2008 2008
-------------- -------------- --------------
GAAP gross margin 31.0 percent 46.2 percent 43.6 percent
Effect of reconciling
items on gross margin 16.1 percent 5.6 percent 7.9 percent
Non-GAAP gross margin 47.1 percent 51.8 percent 51.5 percent
GAAP operating margin (15.9)percent 10.7 percent 9.8 percent
Effect of reconciling
items on operating
margin 33.1 percent 16.2 percent 16.3 percent
Non-GAAP operating
margin 17.2 percent 26.9 percent 26.1 percent
MICROSEMI CORPORATION
Selected Non-GAAP Financial Measures and Schedule Reconciling
Selected Non-GAAP Financial Measures to Comparable GAAP Financial
Measures
(Unaudited, in thousands except for per share amounts)
-------------------- --------------------
Quarter ended Six months ended
-------------------- --------------------
March 29, March 30, March 29, March 30,
2009 2008 2009 2008
--------- --------- --------- ---------
GAAP gross margin $ 32,712 $ 55,199 $ 93,145 $ 107,733
Transitional idle
capacity (a) 6,271 9,976 13,201 20,741
Inventory reserves due
to restructuring
activities (a) 10,204 -- 10,204 --
Impairment of
restructuring related
fixed assets (a) 590 -- 590 --
Manufacturing profit in
acquired inventory (b) -- -- 243 --
--------- --------- --------- ---------
Non-GAAP gross margin $ 49,777 $ 65,175 $ 117,383 $ 128,474
--------- --------- --------- ---------
GAAP operating income
(loss) $ (16,805) $ 12,423 $ (2,893) $ 23,461
Transitional idle
capacity (a) $ 6,271 $ 9,976 $ 13,201 $ 20,741
Inventory reserves due
to restructuring
activities (a) 10,204 -- 10,204 --
Impairment of
restructuring related
fixed assets (a) 590 -- 590 --
Manufacturing profit in
acquired inventory (b) -- -- 243 --
Amortization of
intangible assets (c) 3,562 2,816 6,806 5,915
Stock based
compensation (d) 6,976 5,184 14,891 11,325
In-process research and
development (e) -- -- -- 440
Exceptional legal
expenses (f) 2,111 -- 2,557 --
Restructuring and other
special charges (a) 5,219 2,677 7,640 3,506
--------- --------- --------- ---------
Non-GAAP operating income $ 18,128 $ 33,076 $ 53,239 $ 65,388
--------- --------- --------- ---------
GAAP net income (loss) $ (16,612) $ 9,815 $ (3,404) $ 18,428
Transitional idle
capacity (a) $ 6,271 $ 9,976 $ 13,201 $ 20,741
Inventory reserves due
to restructuring
activities (a) 10,204 -- 10,204 --
Impairment of
restructuring related
fixed assets (a) 590 -- 590 --
Manufacturing profit in
acquired inventory (b) -- -- 243 --
Amortization of
intangible assets (c) 3,562 2,816 6,806 5,915
Stock based
compensation (d) 6,976 5,184 14,891 11,325
In-process research and
development (e) -- -- -- 440
Exceptional legal
expenses (f) 2,111 -- 2,557 --
Restructuring and other
special charges (a) 5,219 2,677 7,640 3,506
Income tax effect on
non-GAAP adjustments
(g) (3,511) (5,134) (9,194) (10,617)
--------- --------- --------- ---------
Non-GAAP net income $ 14,810 $ 25,334 $ 43,534 $ 49,738
--------- --------- --------- ---------
GAAP diluted earnings
(loss) per share $ (0.21) $ 0.12 $ (0.04) $ 0.23
Impact of non-GAAP
adjustments on diluted
earnings (loss) per
share 0.40 0.20 0.58 0.40
--------- --------- --------- ---------
Non-GAAP diluted earnings
per share $ 0.19 $ 0.32 $ 0.54 $ 0.63
--------- --------- --------- ---------
Diluted common and common
equivalent shares
outstanding used in
calculating non-GAAP
diluted earnings per
share 79,858 79,518 80,031 79,245
(a) - (g) Please refer to corresponding footnotes above.
MICROSEMI CORPORATION
Condensed Consolidated Balance Sheets
(Unaudited, in thousands)
March 29, September 28,
2009 2008
--------- ------------
ASSETS
Current assets:
Cash and cash equivalents $ 185,827 $ 107,197
Investment in auction rate securities -- 62,000
Accounts receivable, net 84,512 103,467
Inventories 118,131 121,726
Other current assets 26,652 24,296
--------- ---------
Total current assets 415,122 418,686
Investment in auction rate securities 46,550 --
Other non-current assets 352,778 341,922
--------- ---------
TOTAL ASSETS $ 814,450 $ 760,608
========= =========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities $ 61,905 $ 67,226
Auction rate securities credit facility 46,550 --
Other long-term liabilities 21,421 20,212
Shareholders' equity 684,574 673,170
========= =========
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 814,450 $ 760,608
========= =========
Balance Sheet Note
At March 29, 2009 and September 28, 2008, investment in auction rate securities consisted of auction rate bonds backed by student loans. We have entered into a settlement agreement with the financial institution where we hold these investments and per the terms of the settlement agreement: a) in the quarter ended December 28, 2008, the financial institution repurchased our $15.5 million investment in auction rate preferred shares at par plus accrued interest; b) we hold rights to sell our $46.6 million investment in auction rate bonds back to the financial institution at par plus accrued interest beginning June 30, 2010; and c) the ability to borrow via a "no net cost" credit facility, the full par value of our investment in auction rate bonds.
During the quarter ended March 29, 2009, we monetized all auction rate securities at full par value of $46.6 million via the "no net cost" credit facility, which resulted in an increase to cash and auction rate securities credit facility of $46.6 million, respectively. While the financial institution where we hold our investment in auction-rate securities may redeem them prior to June 30, 2010, we intend to put these securities and use the proceeds to repay the credit facility no later than June 30, 2010. As such, in the current quarter, we have classified both the investment and credit facility as non-current.
Notes Reconciling Non-GAAP Financial Information to GAAP Financial Information
To supplement the consolidated financial results prepared in accordance with Generally Accepted Accounting Principles ("GAAP"), this press release and its attachments include non-GAAP financial measures that exclude transitional idle capacity, inventory reserves due to restructuring activities, impairment of restructuring related fixed assets, effects of manufacturing profit in acquired inventory, amortization of acquisition-related intangible assets, stock based compensation, in-process research and development, exceptional legal expenses, restructuring, reserve valuations and other special charges or credits. Management excludes these items because it believes that the non-GAAP measures enhance an investor's overall understanding of the Company's financial performance and future prospects by being more reflective of the Company's core operational activities and to be more comparable with the results of the Company over various periods. Management uses non-GAAP financial measures internally for strategic decision making, forecasting future results and evaluating current performance. Guidance is provided only on a non-GAAP basis due to the inherent difficulty of forecasting the timing or amount of certain items that have been excluded from the forward-looking non-GAAP measures, and a reconciliation to the comparable GAAP guidance has not been provided because certain factors that are materially significant to the Company's ability to estimate the excluded items are not accessible or estimable on a forward-looking basis. By disclosing non-GAAP financial measures, management intends to provide investors with a more meaningful, consistent comparison of the Company's core operating results and trends for the periods presented. Non-GAAP financial measures are not prepared in accordance with GAAP; therefore, the information is not necessarily comparable to other companies' financial information and should be considered as a supplement to, not a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP.
The items excluded from GAAP financial results in calculating non-GAAP financial results, are set forth below:
(a) Restructuring activities the closure and consolidation of our
manufacturing facilities. As these facilities are not expected to
have a continuing contribution to operations or have a
diminishing contribution during the transition phase, management
believes excluding such items from the Company's operations
provides investors with a means of evaluating the Company's on-
going operations. Restructuring activities also include cost
reduction measures to balance our operations to meet customer
demand. Transitional idle capacity relates to unused
manufacturing capacity and non-productive manufacturing expenses
during the period from when shutdown activities commence to when
all transition activities are completed. Inventory reserves due
to restructuring activities and impairment of restructuring
related fixed assets relate to the exiting of product that do not
meet profitability metrics or products with recent substantial
declines in projected demand. Restructuring and other special
charges include severance and other costs related to facilities
in the process of closing or already closed. Management excludes
these expenses when evaluating core operating activities and for
strategic decision making, forecasting future results and
evaluating current performance.
(b) Manufacturing profit in acquired inventory resulted from purchase-
accounting adjustments to increase the value of inventory
acquired to its fair value. As the acquired inventory is sold,
the associated manufacturing profit in acquired inventory
increases cost of goods sold and reduces gross margin. The
manufacturing profit in acquired inventory has been excluded to
facilitate comparability of gross margin between periods. In
addition, management excludes the impact of manufacturing profit
in acquired inventory in internal measurements of gross margin as
it does not reflect continuing operations at acquired operations.
(c) While amortization of acquisition related intangible assets is
expected to continue in the future, for internal analysis of the
Company's operations, management does not view this expense as
reflective of the business' current performance.
(d) Stock based compensation in connection with the SFAS123R has been
excluded as management excludes these expenses when evaluating
core operating activities and for strategic decision making,
forecasting future results and evaluating current performance.
(e) In-process research and development has been excluded to
facilitate the comparability of expenses between periods. In
addition, management does not include IPR&D, an acquisition-
related charge, in measuring core research and development costs,
nor does it believe that IPR&D is indicative of current or future
spending.
(f) Amounts relate to expenses from previously disclosed matters and
actions related the Department of Justice, International Trade
Commission and an independent inquiry conducted by our Board of
Directors. Management excludes these expenses when evaluating
core operating activities and for strategic decision making,
forecasting future results and evaluating current performance.
(g) The tax effect on non-GAAP adjustments represented the difference
in the provision for income taxes that resulted from non-GAAP
adjustments to pretax income and also certain acquisition-related
and nondeductible stock-based compensation items.